Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Gestational trophoblastic tumors].

J P Droz1, C Lhommé

  • 1Département de médecine, Institut Gustave-Roussy, Villejuif.

La Revue Du Praticien
|April 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microbiological epidemiology and antibiotic susceptibility of infected meshes after prosthetic abdominal wall repair.

Journal of visceral surgery·2023
Same author

Long-term fatigue and quality of life among epithelial ovarian cancer survivors: a GINECO case/control VIVROVAIRE I study.

Annals of oncology : official journal of the European Society for Medical Oncology·2019
Same author

Neoadjuvant chemotherapy (NACT) increases immune infiltration and programmed death-ligand 1 (PD-L1) expression in epithelial ovarian cancer (EOC).

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same author

Health-related quality of life in women with recurrent ovarian cancer receiving paclitaxel plus trebananib or placebo (TRINOVA-1).

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same author

Novel membrane-based targets - Therapeutic potential in gynecological cancers.

Critical reviews in oncology/hematology·2014
Same author

Actinomycin D, cisplatin, and etoposide regimen is associated with almost universal cure in patients with high-risk gestational trophoblastic neoplasia.

European journal of cancer (Oxford, England : 1990)·2014

Gestational trophoblastic tumours, including moles and choriocarcinomas, are rare but highly chemosensitive. The goal is to cure all patients while preserving fertility, using prognostic factors and HCG markers for tailored treatment.

Area of Science:

  • Gynecologic Oncology
  • Reproductive Endocrinology
  • Medical Biochemistry

Context:

  • Gestational trophoblastic tumours (GTTs) encompass a spectrum of rare gynecologic malignancies.
  • These include hydatidiform moles, invasive moles, and choriocarcinomas.
  • GTTs are characterized by remarkable chemosensitivity.

Purpose:

  • To achieve complete cure for all patients diagnosed with GTTs.
  • To preserve the reproductive potential and fertility of affected individuals.
  • To individualize treatment strategies based on identified prognostic factors.

Summary:

  • GTTs are rare gynecologic neoplasms with high response rates to chemotherapy.
  • Prognostic factors are crucial for tailoring treatment regimens to individual patient needs.

Related Experiment Videos

  • Human chorionic gonadotropin (HCG) and beta-HCG serve as reliable diagnostic and monitoring biomarkers.

    • Impact:

    • Enables personalized treatment approaches for GTTs, improving patient outcomes.
    • Facilitates the preservation of childbearing potential in women treated for GTTs.
    • Advances in immunochemistry provide accurate diagnostic and follow-up tools for GTT management.